GIUGGIOLI, DILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.487
EU - Europa 14.594
AS - Asia 6.254
SA - Sud America 692
AF - Africa 80
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 15
Totale 42.143
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.344
IT - Italia 5.531
GB - Regno Unito 4.440
SG - Singapore 1.836
CN - Cina 1.736
HK - Hong Kong 1.448
SE - Svezia 1.176
DE - Germania 784
BR - Brasile 607
RU - Federazione Russa 542
UA - Ucraina 534
TR - Turchia 467
FR - Francia 430
FI - Finlandia 411
BG - Bulgaria 223
ID - Indonesia 200
NL - Olanda 154
IN - India 152
KR - Corea 125
CA - Canada 80
IE - Irlanda 71
VN - Vietnam 64
JP - Giappone 50
BE - Belgio 45
AT - Austria 39
ZA - Sudafrica 36
LT - Lituania 35
IR - Iran 29
MY - Malesia 29
AR - Argentina 26
BZ - Belize 26
MX - Messico 25
RO - Romania 23
CH - Svizzera 21
CZ - Repubblica Ceca 21
ES - Italia 20
AU - Australia 17
PL - Polonia 16
BD - Bangladesh 13
EG - Egitto 13
EU - Europa 13
IQ - Iraq 13
MA - Marocco 12
PK - Pakistan 12
CL - Cile 10
CO - Colombia 10
EC - Ecuador 10
IL - Israele 10
PE - Perù 10
TW - Taiwan 10
HU - Ungheria 9
PT - Portogallo 9
LV - Lettonia 8
BY - Bielorussia 7
KE - Kenya 7
TH - Thailandia 7
VE - Venezuela 7
AL - Albania 6
AZ - Azerbaigian 6
LU - Lussemburgo 6
TN - Tunisia 6
UY - Uruguay 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
KG - Kirghizistan 5
KZ - Kazakistan 5
SA - Arabia Saudita 5
NO - Norvegia 4
NZ - Nuova Zelanda 4
PH - Filippine 4
PY - Paraguay 4
RS - Serbia 4
AM - Armenia 3
EE - Estonia 3
JM - Giamaica 3
MK - Macedonia 3
NP - Nepal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
GT - Guatemala 2
HR - Croazia 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
PA - Panama 2
SI - Slovenia 2
BB - Barbados 1
BH - Bahrain 1
CM - Camerun 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
IM - Isola di Man 1
IS - Islanda 1
KH - Cambogia 1
MV - Maldive 1
Totale 42.133
Salva come PNG Salva come JPEG
Città #
Southend 3.361
Santa Clara 2.970
Fairfield 2.598
Woodbridge 1.481
Hong Kong 1.444
Chandler 1.325
Ashburn 1.295
Houston 1.172
Singapore 1.126
Jacksonville 940
Seattle 924
Wilmington 846
Cambridge 829
Ann Arbor 740
Nyköping 679
London 657
Dearborn 621
Hefei 409
Milan 396
Modena 350
Rome 344
Izmir 296
Beijing 294
San Diego 284
Helsinki 236
Princeton 234
Sofia 220
Jakarta 193
New York 184
Bologna 179
Eugene 157
Moscow 155
Council Bluffs 143
Los Angeles 132
Shanghai 126
Bremen 120
Florence 107
Redwood City 104
Seoul 96
Naples 95
Des Moines 90
Palermo 85
Frankfurt am Main 78
The Dalles 69
Atlanta 68
Parma 65
Falls Church 59
Bari 57
Guangzhou 57
Dublin 56
Catania 54
São Paulo 53
Turin 53
Norwalk 50
San Jose 50
Chicago 48
Padova 47
Genoa 46
Boardman 43
Verona 42
Brussels 39
Munich 36
Cagliari 34
Reggio Emilia 34
Nuremberg 33
Delhi 32
Lauterbourg 32
New Delhi 30
Portsmouth 29
Kunming 28
Phoenix 28
Tokyo 27
Belize City 26
Dong Ket 26
Toronto 26
Brescia 25
Belo Horizonte 24
Dallas 24
Hounslow 24
Nanjing 24
Trieste 24
Amsterdam 23
Johannesburg 23
Ottawa 22
Salerno 22
Pisa 21
San Francisco 21
Treviso 20
Turku 19
Jinan 18
San Mateo 18
Columbus 17
Indiana 17
Kilburn 17
Lappeenranta 17
Messina 17
Perugia 17
Venice 17
Wuhan 17
Brno 16
Totale 29.996
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.515
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 770
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 725
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 699
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 344
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 321
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 317
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 283
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 278
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 266
Current treatment of hepatitis C-associated rheumatic diseases. 262
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 261
Elevated Troponin Serum Levels in Adult Onset Still's Disease 256
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 252
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 251
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 250
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 249
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 245
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 245
Aortic pulse wave velocity measurement in systemic sclerosis patients. 244
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 235
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 233
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 231
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 230
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 229
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 228
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 227
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 227
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 226
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 225
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 225
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 224
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 223
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 222
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 220
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 219
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 216
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 215
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 213
Thymus alterations and systemic sclerosis 213
Associations between Systemic Sclerosis and Thyroid Diseases 213
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 212
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. 211
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 210
HCV-related rheumatic manifestations and therapeutic strategies 209
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 209
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 206
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 205
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 203
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 203
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 201
Renal Manifestations of Hepatitis C Virus 199
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 198
Heart involvement and systemic sclerosis 194
Scleroderma digital ulcers complicated by infection with fecal pathogens. 194
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis 193
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 193
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 193
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 193
Systemic sclerosis following human cytomegalovirus infection 192
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 192
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 192
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 192
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 191
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 190
The safety of iloprost in systemic sclerosis in a real-life experience 189
Phantom Limb Pain in Patients with Severe Cryoglobulinemic Vasculitis: Usefulness of Long-Term Pregabalin Treatment 188
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 188
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 188
Amlodipine in the treatment of Raynaud's phenomenon 187
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 187
Treatment of HCV-related mixed cryoglobulinemia 186
Novel Therapies for Thyroid Autoimmune Diseases 185
Cardiovascular risk and prostanoids in systemic sclerosis 183
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 182
Procedural pain management in the treatment of scleroderma digital ulcers 182
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 181
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 180
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 179
L-Arginine in pregnant scleroderma patients 179
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 178
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 177
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 176
Severe alopecia complicating systemic sclerosis 176
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 176
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 175
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 173
Osteomyelitis complicating scleroderma digital ulcers. 172
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 171
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 170
Right ventricular overload and cardiovascular neuroendocrine derangement in systemic sclerosis 168
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 167
Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature 164
Human Parvovirus B19 (B19V) Infection in Systemic Sclerosis Patients 164
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 164
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 163
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 162
DANCE CLASS DEDICATED TO SCLERODERMA PATIENTS: JOINT EVALUATION, FUNCTIONAL AND QUALITY OF LIFE BEFORE AND AFTER TREATMENT – CLINICAL TRIAL 162
Platelet gel in the treatment of severe scleroderma skin ulcers. 162
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 162
Totale 25.648
Salva come PNG Salva come JPEG
Categoria #
all - tutte 189.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.230
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020217 0 0 0 0 0 0 0 0 0 0 0 217
2020/20215.943 384 213 333 460 579 492 1.048 796 315 526 494 303
2021/20224.403 221 363 353 386 166 334 194 269 463 381 741 532
2022/20235.029 579 419 282 369 592 677 260 478 651 153 324 245
2023/20244.331 184 282 254 492 753 327 363 472 109 237 349 509
2024/202511.764 472 216 243 827 2.233 1.779 830 635 1.329 769 1.254 1.177
Totale 42.685